SOURCE: The Bedford Report

The Bedford Report

July 05, 2011 08:16 ET

Boston Scientific and Stryker Put Larger Emphasis on International Markets

The Bedford Report Provides Stock Research on Boston Scientific & Stryker

NEW YORK, NY--(Marketwire - Jul 5, 2011) - As the economies in emerging markets continue to grow at a rapid pace, healthcare access has become both far more widespread and higher quality. Many companies in the medical supplies sector are looking to these emerging markets as a means to supplement the tepid growth of domestic medical instrument and supply markets. The Bedford Report examines the outlook for companies in the Medical Equipment & Supplies Industry and provides investment research on Boston Scientific Corporation (NYSE: BSX) and Stryker Corporation (NYSE: SYK). Access to the full company reports can be found at:

www.bedfordreport.com/BSX

www.bedfordreport.com/SYK

Boston Scientific CEO J. Raymond Elliott recently said the company will be "putting a big emphasis on international" going forward. Boston Scientific is investing significantly in its direct presence in India, with an emphasis on critically important therapeutic areas such as Interventional Cardiology, Cardiac Rhythm Management and Electrophysiology, Peripheral Interventions, Endoscopy, Urology, and Women's Health.

The Bedford Report releases stock reports on the Medical Equipment & Supplies Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.

Stryker Corporation is a worldwide leader in the orthopaedic market and is one of the largest medical device companies. The company recently opened its first manufacturing plant in the eastern part of China which Stryker believes "provides a state-of-the-art manufacturing environment."

Last week Stryker Corporation said it completed its $316 million acquisition of Pennsylvania-based orthobiologic and biosurgery products maker Orthovita Inc.

The Bedford Report provides Investment Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.bedfordreport.com/disclaimer

Contact Information